Literature DB >> 15674485

Neuro-oncology in a nutshell.

Joachim M Baehring1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15674485     DOI： 10.1007/s11060-004-5394-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  21 in total

1.  HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.

Authors:  Gentao Liu; Han Ying; Gang Zeng; Christopher J Wheeler; Keith L Black; John S Yu
Journal:  Cancer Res       Date:  2004-07-15       Impact factor: 12.701

2.  Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry.

Authors:  Joanne M Hilden; Sharon Meerbaum; Peter Burger; Jonathan Finlay; Anna Janss; Bernd W Scheithauer; Andrew W Walter; Lucy B Rorke; Jaclyn A Biegel
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

3.  Recommended guidelines for the treatment of cancer treatment-induced diarrhea.

Authors:  Al B Benson; Jaffer A Ajani; Robert B Catalano; Constance Engelking; Steven M Kornblau; James A Martenson; Richard McCallum; Edith P Mitchell; Thomas M O'Dorisio; Everett E Vokes; Scott Wadler
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

4.  Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.

Authors:  Jill S Barnholtz-Sloan; Andrew E Sloan; Faith G Davis; Fawn D Vigneau; Ping Lai; Raymond E Sawaya
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

5.  Clonal evolution as pathogenetic mechanism in relapse of primary CNS lymphoma.

Authors:  H Pels; M Montesinos-Rongen; C Schaller; D Van Roost; U Schlegel; O D Wiestler; M Deckert
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

6.  Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.

Authors:  Fabrice Bonnet; Charlotte Lewden; Thierry May; Laurence Heripret; Eric Jougla; Sibylle Bevilacqua; Dominique Costagliola; Dominique Salmon; Geneviève Chêne; Philippe Morlat
Journal:  Cancer       Date:  2004-07-15       Impact factor: 6.860

7.  The LKB1 tumor suppressor negatively regulates mTOR signaling.

Authors:  Reuben J Shaw; Nabeel Bardeesy; Brendan D Manning; Lyle Lopez; Monica Kosmatka; Ronald A DePinho; Lewis C Cantley
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

8.  Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors.

Authors:  Susan M Chang; Wendy Seiferheld; Walter Curran; R Share; J Atkins; Ali Choucair; J Kresl; Louisa Thoron; Gregory Cairncross; Mark Gilbert; Jean-Paul Bahary; Carol Dolinskas; David N Louis; Peter Bushunow; Jan Buckner; Geoffrey Barger; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-15       Impact factor: 7.038

9.  Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years.

Authors:  Cordelia Luyken; Ingmar Blümcke; Rolf Fimmers; Horst Urbach; Otmar D Wiestler; Johannes Schramm
Journal:  Cancer       Date:  2004-07-01       Impact factor: 6.860

10.  Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity.

Authors:  Deborah P Waber; Lewis B Silverman; Lori Catania; William Mautz; Montse Rue; Richard D Gelber; Donna E Levy; Meredith A Goldwasser; Heather Adams; Annie Dufresne; Victoria Metzger; Ivonne Romero; Nancy J Tarbell; Virginia Kimball Dalton; Stephen E Sallan
Journal:  J Clin Oncol       Date:  2004-07-01       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.